Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children

Pediatric Infectious Disease Journal

Volumn 15, Issue 5, 1996, Pages 456-460

  Palusci, Vincent J ^a,b   Kaul, Aditya ^a   Lawrence, Robert M ^a   Haines, Kathleen A ^a   Kwittken, Pamela L ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b HELEN DEVOS CHILDREN S HOSPITAL   (United States)

Author keywords

desensitization; Trimethoprim sulfamethoxazole

Indexed keywords

COTRIMOXAZOLE;

ANAPHYLAXIS; ARTICLE; CHEMOPROPHYLAXIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DELUSION; DESENSITIZATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HALLUCINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PRURITUS; URTICARIA;

ADMINISTRATION, ORAL; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4-CD8 RATIO; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; FEMALE; HIV INFECTIONS; HUMANS; INFANT; LYMPHOCYTE COUNT; MALE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0029971343     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199605000-00015     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR 1995;44(KR-4):1-11.
2. Simonds EJ, Lindegran ML, Thomas P, et al. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. N Engl J Med 1995;332:786- 90.
3. Alberti-Flor JJ, Hernandez ME, Ferrer JP, Howell S, Jeffers L. Fulminant liver failure and pancreatitis associated with use of sulfamethoxazole-trimethoprim. Am J Gastroenterol 1989;84:1577-9.
4. Boyce TG, Smidt RG, Edmonson MB. Fever as an adverse reaction to oral trimethoprim-sulfamethoxazole therapy. Pediatr Infect Dis J 1992;11:772-3.
5. Chanock SJ, Luginbuhl LM, McIntosh K, Lipshultz SE. Life-threatening reaction to trimethoprim/sulfamethoxazole in pediatric human immunodeficiency virus infection. Pediatrics 1994;93:519-21.
6. Gutman L. The use of trimethoprim-sulfamethoxazole in children: a review of adverse reactions and indications. Pediatr Infect Dis J 1984;3:349-57.
7. Jick H. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis 1982;4:426-8.
8. Jung AC, Paauw DS. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Arch Intern Med 1994;154:2402-6.
9. Absar N, Daneshvar H, Beall G. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients. J Allergy Clin Immunol 1994;93:1001-5.
10. Gandhi R, Reiss JL, Wedner HJ. Drug desensitization (DD) to sulfonamide antibiotics and ASA at Washington University. J Allergy Clin Immunol 1995;95(1 Part 2):286.
11. Gluckstein D, Ruskin J. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ. Clin Infect Dis 1995;20:849-53.
12. Muppidi D, Kalanadhabhatta V, Kramer M. Rapid oral desensitization to trimethoprim/sulfamethoxazole (TMP- SMX) in HIV patients with Pneumocystis carinii pneumonia (POP). J Allergy Clin Immunol 1995;95(1 Part 2):287.
13. Nwadiuko RO, Beall G. Adverse reactions to TMP-SMX? Consider oral desensitization. J Respir Dis 1995;16:447-52.
14. White MV, Haddad ZH, Brunner E, Sainz C. Desensitization to trimethoprim suifamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia. Ann Allergy 1989;62:177-9.
15. Kletzel M, Beck S, Elser J, Shock N, Burks W. Trimethoprimsulfamethoxazole (TMP-SMX) oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions. An J Dis Child 1991; 145:1428-9.
16. Kruez W, Gungor T, Lotz C, Funk M, Kornhuber B. "Treating through" hypersensitivity to co-trimoxazole in children with HIV infection. Lancet 1990;336:1508-9.
17. Nagaraian R, Nelson RP, Day NK, Good RA. Trimethoprim- sulfamethoxazole sensitivity and desensitization in HIV- infected children. J Allergy Clin Immunol 1995;95(1 Part 2):287.
18. Yango MC, Kim K, Evans R. Oral desensitization to trimethoprim-sulfamethoxazole in pediatric patients. Imm Allergy Pract 1992;14:17-24.
19. Centers for Disease Control and Prevention. Classification of pediatric HIV infection. MMWR 1994;43(RR-12):1-7.
20. Carr A, Gross AS, Hoskins JM, Penny R, Cooper DA. Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulfamethoxazole in HIV-infected patients. AIDS 1994;8:333-7.
21. Mathelier-Fusade P, Leynadier F. Intolerance to sulfonamides in HIV infected subjects: toxic and allergic origin. Presse Med 1993;22:1363-5.
22. Carr A, Swanson C, Penny R, Cooper DA. Clinical and laboratory markers of hypersensitivity to trimethoprim- sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J Infect Dis 1993;167:180-5.
23. Carrington DM, Earl HS, Sullivan TJ. Studies of human IGE to a sulfonamide determinant. J Allergy Clin Immunol 1987; 79:442-7.
24. Harle DG, Baldo BA, Smal MA, Van Nunen SA. An immunoassay for the detection of IgE antibodies to trimethoprim in the sera of allergic patients. Clin Allergy 1987;17:209-16.
25. Macy EM. Current sulfamethoxazole skin tests reagents fail to predict recurrent adverse reactions. J Allergy Clin Immunol 1995;95(1 Part 2):171.
26. Hardy WD, Feinberg J, Finkelstein, et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;327:1842-8.